antibody-drug conjugate
Reveal Genomics, Ona Therapeutics Partner on Molecular Tumor Analysis
The partnership is aided by a grant of undisclosed size from the Spanish Ministry of Science, Innovation, and Universities.
NICE Recommends Adcetris for CD30-Positive Hodgkin Lymphoma
Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.
Elevation Oncology Narrows EO-3021 Trial to Claudin 18.2-Expressing Patients, Launches Combo Cohorts
The firm is using immunohistochemistry to gauge biomarker expression before enrolling patients in a trial of its CLDN 18.2-directed antibody-drug conjugate.
FDA Grants Priority Review to AstraZeneca, Daiichi Sankyo's Dato-DXd
In a pooled analysis from two trials, Dato-DXd has shown promise as a treatment for advanced EGFR-mutated NSCLC.
AstraZeneca, Daiichi Sankyo Withdraw EU Application for Dato-DXd in Nonsquamous NSCLC
The decision follows a similar one in the US and is due to the drug's failure to significantly improve overall survival versus chemo in the TROPION-Lung01 trial.
Jul 11, 2024
Myricx Bio Raises £90M in Series A Financing
Mar 14, 2024
Tubulis Raises $139M in Series B2 Funding
Oct 25, 2023